1,2-Dichlor-hexanol-(6) | 925-65-5

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1,2-Dichlor-hexanol-(6)
• 英文别名: 5,6-Dichlor-1-hexanol；5,6-Dichlor-hexanol-(1)；5,6-dichloro-hexan-1-ol；5,6-Dichlorohexan-1-ol
• CAS: 925-65-5
• 化学式: C₆H₁₂Cl₂O
• 分子量: 171.067
• InChiKey: ORUFITYOANCCQU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  9
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  5-己烯-1-醇 在 aluminum (III) chloride 、 氧气 、 三异丙氧基氧化钒 、 四丁基碘化铵 作用下， 以 乙腈 为溶剂， 反应 24.0h， 以65%的产率得到1,2-Dichlor-hexanol-(6)
  参考文献：
  名称：

  分子氧下钒催化的氯化反应

  摘要：

  在大分子分子氧下，在Bu 4 NI和AlCl 3存在下，使用钒催化剂进行酮的催化氯化反应。该催化氯化可用于烯烃的氯化以得到相应的vic-二氯化物。发现AlCl 3既充当路易斯酸又充当氯化物源，以诱导容易的氯化。在大气分子氧下，在钒催化剂存在下，Bu 4 NI和AlI 3的组合可诱导酮的碘化。

  DOI：

  10.1016/j.jinorgbio.2015.01.015

文献信息

• [EN] HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF STRESS-RELATED CONDITIONS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES POUR LE TRAITEMENT D'ÉTATS LIÉS AU STRESS
  申请人：OTSUKA PHARMA CO LTD

  公开号：WO2010137738A1

  公开（公告）日：2010-12-02

  The present invention provides a novel heterocyclic compound. A heterocyclic compound represented by general formula (1) wherein, R1 and R2, each independently represent hydrogen; a phenyl lower alkyl group that may have a substituent(s) selected from the group consisting of a lower alkyl group and the like on a benzene ring and/or a lower alkyl group; or a cyclo C3-C8 alkyl lower alkyl group; or the like; R3 represents a lower alkynyl group or the like; R4 represents a phenyl group that may have a substituent(s) selected from the group consisting of a 1,3,4-oxadiazolyl group that may have e.g., halogen or a heterocyclic group selected from pyridyl group and the like; the heterocyclic group may have at least one substituent(s) selected from a lower alkoxy group and the like or a salt thereof.

  本发明提供了一种新颖的杂环化合物。一种由通式（1）表示的杂环化合物，其中，R1和R2分别独立表示氢；苯基较低烷基基团，可能在苯环和/或较低烷基基团上具有从较低烷基基团等组成的取代基；或环C3-C8烷基较低烷基基团；或类似物；R3表示较低炔基基团或类似物；R4表示可能具有从1,3,4-噁二唑基团（例如，卤素）或从吡啶基团等组成的取代基的苯基团；所述杂环基可能具有至少一个从较低烷氧基等选择的取代基或其盐。
• Merging shuttle reactions and paired electrolysis for reversible vicinal dihalogenations
  作者：Xichang Dong、Johannes L. Roeckl、Siegfried R. Waldvogel、Bill Morandi

  DOI：10.1126/science.abf2974

  日期：2021.1.29

  shuttle (e-shuttle) paradigm for the facile and scalable interconversion of alkenes and vicinal dihalides, a class of reactions that can be used both to synthesize useful dihalogenated molecules from simple alkenes and to recycle waste material through retro-dihalogenation. The reaction is demonstrated using 1,2-dibromoethane, as well as 1,1,1,2-tetrachloroethane or 1,2-dichloroethane, to dibrominate or

  邻二溴化物和二氯化物是重要的商品化学品，也是现代化学中必不可少的合成中间体，传统上是使用危险的元素氯和溴合成的。同时，卤化污染物在环境中的持久性要求改进方法以加速其修复。在这里，我们引入一个电化学辅助梭（E-梭）范式烯烃和邻位二卤化物的容易和可扩展的相互转换，一类反应，可用于既从简单的烯烃，并再循环废料通过合成有用二卤代分子复古-二卤代。用1,2-二溴乙烷，1,1,1,2-四氯乙烷或1,2-二氯乙烷分别通过廉价的石墨电极以简单的设置分别对多种烯烃进行二溴化或二氯化反应，证明了该反应。相反，可以使用简单的烯烃受体将六氯化持久性污染物林丹完全脱氯为土壤样品中的苯。
• The α-halogenation of α,β-unsaturated carbonyls and dihalogenation of alkenes using bisacetoxyiodobenzene/pyridine hydrohalides
  作者：Marsewi Ngatimin、Christopher J. Gartshore、Jeremy P. Kindler、Sudha Naidu、David W. Lupton

  DOI：10.1016/j.tetlet.2009.08.038

  日期：2009.11

  A procedure for the α-chlorination or bromination of a number of α,β-unsaturated carbonyls, and the dichlorination or bromination of alkenes, is developed using bisacetoxyiodobenzene (BAIB) and the HCl or HBr salt of pyridine. The reaction proceeds in an acceptable to a good yield and has a broad substrate scope. The dibromination is also achieved using a chiral I[V] reagent, although little enantioselectivity

  使用双乙酰氧基碘苯（BAIB）和吡啶的HCl或HBr盐开发了多种α，β-不饱和羰基的α-氯化或溴化方法，以及烯烃的二氯化或溴化方法。反应以可接受的产率进行，并具有良好的收率，并且具有广泛的底物范围。尽管可以实现很少的对映选择性，但是也可以使用手性I [V]试剂实现二溴化。
• [EN] METHOD OF PRODUCING AMINOPHENOL COMPOUNDS<br/>[FR] PROCEDE DE FABRICATION DE COMPOSES AMINOPHENOLS
  申请人：OTSUKA PHARMA CO LTD

  公开号：WO2005092832A1

  公开（公告）日：2005-10-06

  The present invention provides an industrially advantageous method of producing aminophenol compounds represented by the formula (1) by a simple and easy procedure at a high yield and a high purity. The present invention provides a method of producing an aminophenol compound represented by the formula (1): (wherein each of R1 and R2, which may be the same or different, is a hydrogen atom, a substituted or unsubstituted lower alkyl group or the like; R1 and R2, taken together with the adjacent nitrogen atom, may form a 5- or 6-membered heterocycle with or without other intervening heteroatoms; the heterocycle may be substituted by 1 to 3 substituents selected from the group consisting of a hydroxyl group, a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted aryloxy group and the like; and the hydroxyl group in the formula (1) is substituted on the 2- or 4-position to the amino group on the phenyl ring), which comprises allowing a cyclohexanedione compound represented by the formula (2) to react with an amine compound represented by the formula (3) (wherein R1 and R2 are as defined above), under a neutral or basic condition.

  本发明提供一种在高产率和高纯度下通过简单易行的程序生产由式（1）表示的氨基酚化合物的工业上有利的方法。本发明提供了一种生产由式（1）表示的氨基酚化合物的方法：（其中R1和R2中的每一个，可能相同也可能不同，是氢原子，取代或未取代的较低烷基基团或类似物；R1和R2与相邻氮原子一起可以形成5或6成员的杂环，有或无其他插入的杂原子；该杂环可以被1至3个取代基取代，所述取代基选自羟基团、取代或未取代的较低烷基基团、取代或未取代的芳基基团、取代或未取代的芳氧基团等；并且在式（1）中的羟基团被取代在苯环上的氨基团的2-或4-位置），其包括使由式（2）表示的环己二酮化合物与由式（3）表示的胺化合物（其中R1和R2如上定义）在中性或碱性条件下反应。
• DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS
  申请人：Matsuyama Hironori

  公开号：US20100004438A1

  公开（公告）日：2010-01-07

  An object of the present invention is to provide a medicinal drug much improved in anti tumor activity and excellent in safety. According to the present invention, there is provided a medicinal drug containing a compound represented by the following general formula (1) or a salt thereof as an active ingredient: [Formula 1] wherein X 1 represents a nitrogen atom or a group —CH═, R 1 represents a group -Z-R 6 , in which Z represents a group —CO—, a group —CH(OH)— or the like, R 6 represents a 5- to 15-membered monocyclic, dicyclic or tricyclic saturated or unsaturated heterocyclic group having 1 to 4 nitrogen atoms, oxygen atoms or sulfur atoms, R 2 represents a hydrogen atom or a halogen atom, Y represents a group —O—, a group —CO—, a group —CH(OH)— or a lower alkylene group, and A represents [Formula 2] wherein R 3 represents a hydrogen atom, a lower alkoxy group or the like, p represents 1 or 2, R 4 represents an imidazolyl lower alkyl group or the like.

  本发明的一个目的是提供一种在抗肿瘤活性方面大大改进且安全性优异的药物。根据本发明，提供了一种包含以下一般式（1）所表示的化合物或其盐作为活性成分的药物：[式1]其中X1代表氮原子或基团—CH═，R1代表一个基团-Z-R6，其中Z代表基团—CO—，基团—CH(OH)—或类似的基团，R6代表一个含有1至4个氮原子、氧原子或硫原子的5至15个成员的单环、双环或三环饱和或不饱和杂环基团，R2代表氢原子或卤原子，Y代表基团—O—，基团—CO—，基团—CH(OH)—或低碳烷基基团，A代表[式2]其中R3代表氢原子、低碳氧基基团或类似基团，p代表1或2，R4代表咪唑基低碳基团或类似基团。